T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Bristow Group
VTOL
$1.38B
| $561K | ﹤0.01% |
15,538
+1,321
| +9% | +$48.5K |
|
2302
CareDx
CDNA
$2.45B
| $560K | ﹤0.01% |
38,507
+3,964
| +11% | +$56.5K |
|
|
CTEV
2303
Claritev Corp
CTEV
$716M
| $560K | ﹤0.01% |
10,546
+223
| +2% | +$12.3K |
|
|
ACR
2304
ACRES Commercial Realty
ACR
$101M
| $558K | ﹤0.01% |
26,351
| – | – |
|
2305
ClearPoint Neuro
CLPT
$470M
| $558K | ﹤0.01% |
25,587
+1,132
| +5% | +$13.3K |
|
2306
Old Second Bancorp
OSBC
$1.31B
| $558K | ﹤0.01% |
32,243
+4,900
| +18% | +$88.2K |
|
2307
Akebia Therapeutics
AKBA
$241M
| $555K | ﹤0.01% |
203,169
+19,905
| +11% | +$66.2K |
|
2308
Acco Brands
ACCO
$399M
| $553K | ﹤0.01% |
138,515
+4,857
| +4% | +$18.9K |
|
|
NFBK
2309
DELISTED
Northfield Bancorp
NFBK
| $553K | ﹤0.01% |
46,827
+1,692
| +4% | +$19.4K |
|
2310
EVgo
EVGO
$519M
| $549K | ﹤0.01% |
116,038
-37,546
| -24% | -$146K |
|
2311
LSI Industries
LYTS
$912M
| $544K | ﹤0.01% |
23,029
-4,853
| -17% | -$98.7K |
|
2312
RUM Group Inc
RUM
$3.74B
| $543K | ﹤0.01% |
74,974
+17,796
| +31% | +$145K |
|
2313
Core Laboratories
CLB
$569M
| $536K | ﹤0.01% |
43,342
+1,305
| +3% | +$15.3K |
|
2314
Aspen Aerogels
ASPN
$504M
| $534K | ﹤0.01% |
76,626
+5,749
| +8% | +$40.5K |
|
2315
Dole
DOLE
$1.26B
| $533K | ﹤0.01% |
39,633
-218,786
| -85% | -$3.07M |
|
2316
Opko Health
OPK
$1.04B
| $533K | ﹤0.01% |
343,286
-94,220
| -22% | -$129K |
|
|
NAGE
2317
Niagen Bioscience
NAGE
$241M
| $533K | ﹤0.01% |
57,127
+2,382
| +4% | +$24.1K |
|
2318
Navitas Semiconductor
NVTS
$3.57B
| $529K | ﹤0.01% |
73,178
+5,455
| +8% | +$36.5K |
|
2319
Levi Strauss
LEVI
$8.63B
| $527K | ﹤0.01% |
22,608
| – | – |
|
2320
Movado Group
MOV
$796M
| $527K | ﹤0.01% |
27,728
+751
| +3% | +$13K |
|
2321
SI-BONE Inc
SIBN
$849M
| $526K | ﹤0.01% |
35,700
+1,210
| +4% | +$19.8K |
|
|
AD
2322
Array Digital Infrastructure
AD
$3.09B
| $521K | ﹤0.01% |
10,399
-13
| -0.1% | -$808 |
|
2323
Dave & Buster's
PLAY
$370M
| $519K | ﹤0.01% |
28,550
+807
| +3% | +$21.2K |
|
2324
Sana Biotechnology
SANA
$1.1B
| $519K | ﹤0.01% |
146,117
-2,411,708
| -94% | -$8.72M |
|
2325
Amprius Technologies
AMPX
$1.74B
| $517K | ﹤0.01% |
49,115
-273,892
| -85% | -$2.15M |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.